Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

Measures of cognition were especially important predictive features of clinical diagnosis. Prediction accuracy was higher in a sample that had longer follow-up, better balance across diagnostic outcomes, and both self- and informant-report independent function measures. Algorithmic diagnosis might be a meaningful substitute for clinical diagnosis in studies in which clinical evaluation and diagnosis are not feasible for all participants and may provide a standardized alternative when clinical diagnosis is available. HIGHLIGHTS: A machine learning algorithm was used to diagnose cognitive impairment and dementia. Measures of cognition were strongest predictive features for clinical diagnosis. Algorithm accuracy was improved by informant-report independent function measures. Algorithmic diagnosis might be an alternative if clinical diagnosis is not feasible. Standardization is an important advantage of algorithmic diagnosis.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Mungas, D., Gavett, B. E., Rojas‐Saunero, L. P., Zhou, Y., Hayes‐Larson, E., Shaw, C. L., et al. (2025). Machine learning diagnosis of cognitive impairment and dementia in harmonized older adult cohorts. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70508

Vancouver

Mungas D, Gavett BE, Rojas‐Saunero LP, Zhou Y, Hayes‐Larson E, Shaw CL, et al. Machine learning diagnosis of cognitive impairment and dementia in harmonized older adult cohorts. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70508. PMID: 40747592.

BibTeX

@article{mungas2025-40747592,
  author  = {Mungas, Dan and Gavett, Brandon E. and Rojas‐Saunero, Liliana Paloma and Zhou, Yixuan and Hayes‐Larson, Eleanor and Shaw, Crystal L. and Farias, Sarah Tomaszewski and Widaman, Keith F. and others},
  title   = {{Machine learning diagnosis of cognitive impairment and dementia in harmonized older adult cohorts}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70508},
  pmid    = {40747592},
  url     = {https://doi.org/10.1002/alz.70508}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

A machine learning algorithm diagnosed cognitive impairment and dementia in harmonized older adult cohorts, with cognition measures as the strongest predictors and better accuracy when informant-report function measures were included. Algorithmic diagnosis is proposed as a possible substitute or standardized alternative to clinical diagnosis, not as a treatment, cure, or prevention.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 1 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.3× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Elizabeth Rose Mayeda: h-index 43 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, Los Angeles: institution h-index 1,923 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 10 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40747592)
Free to read 2 / 2 Free to read
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Digital health tools

See all studies in Digital health tools →